Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children

This is a descriptive prospective community-based seroprevalence study.

Primary objective:

* To determine the prevalence of specific antibodies (immunoglobulin G [IgG]) against dengue in healthy 5 to 10 year-old children in India.

Secondary objectives:

* To determine the dengue virus serotype (DeNV-1,2,3 and /or 4) specific to the antibodies in positive (IgG) samples * To estimate the prevalence of specific antibodies (IgG) against Japanese encephalitis in healthy 5 to 10 year-old children in India.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dengue Arbovirus Infections Dengue Fever Dengue Hemorrhagic Fever Flaviviridae Infections Flavivirus Infections Hemorrhagic Fevers, Viral Infections Mosquito-Borne Diseases RNA Virus Infections Severe Dengue Vector Borne Diseases Virus Diseases

Age range

5 year–10 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kalyani, West Bengali, India

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged between 5 and 10 year-old on the day of inclusion
Healthy child as reported by the parent or legally qualified guardian
Being registered in selected study site
Provision of the informed consent form signed by at least one parent or legally qualified guardian
For children between 8 and 10 years old, provision of the assent form signed.

Exclusion criteria

Treatment and study plan

Primary outcomes

Prevalence of positive samples with dengue specific serotype DENV 1, 2,3 and/or 4

Time frame: Baseline

Secondary outcomes

Prevalence of positive serum samples with JEV specific IgG antibodies

Time frame: Baseline

Sponsors and collaborators

Lead sponsor

Sanofi Pasteur, a Sanofi Company

Industry

Registry information

Official study title

Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children in India

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2013
First posted: Nov 22, 2011
Registry last updated: Jan 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed